The Health Economics Research Groups from two different universities (Universidad de la Rioja, Universidad Publica de Navarra) joint with the consultancy company of Logroño (Mendavilla SL), the Mental Health Service of the Government of Navarre, and the Subdirection of Ambulatory Care Processes and Diagnostics of the Hospital of Navarra, join in a Consortium for:
- Exploring the possibility of applying for projects that evaluate the inclusion of health technologies in eHealth and mHealth.
- Supporting other research groups focused in the area of health technologies, so as to allow them including Economic Evaluations in their projects (health economics being aimed to allow for cross-studies).
- Generating a pool of critic researchers, organizing meetings with experts in the field of Health Economics or different research groups that belong to the Campus Iberus.
LINEAS DE INVESTIGACION
- Economic evaluation of health technologies (dynamic and Markovian modelling of diseases, budget impact analysis of technologies, costs calculations, etc.).
- Health outcomes measures and quality of life analysis.
- Theoretical economic decision making models for health policy and management (patents, research activities of health technology industry, price and reimbursement of drugs, risk-sharing agreements, personalized medicine implementation, etc.).
- Economics of drugs (analysis of the pharmaceutical sector, time series analysis of trends, pricing, consumption, research and development analysis, etc.).
- Quantitative models applied to the health sector (econometric and time series analysis).
PRESENTATION OF THE CONSORTIUM
MEMBERS OF THE CONSORTIUM
IP: Eduardo Sánchez (Universidad Pública de Navarra)
Universidad de La Rioja: Departamento de economía y empresa:
Universidad Pública de Navarra: Departamento Gestión de Empresas
Gobierno de Navarra – Servicio Navarro de Salud. Gerencia de Salud Mental.
Complejo Hospitalario de Navarra – Subdirección Asistencial de Procesos Ambulatorios y Diagnóstico
- Health economics
- Economic evaluation
- Health technologies
- Cost benefit analysis
- Health financing